Join us for the next CBT & VICB Trainee Talks!

🗓 April 16 | 11:00–12:30 (lunch!)
📍 VU (ESB 734) + St. Jude (PRT E1001)

Featuring:
🔬 Huyen (Scarlett) Nguyen
🔬 Nourhan Aboomar

#VICB #ChemicalBiology #TraineeTalks #StJude

📢 Upcoming #VICB Seminar

Caroline Proulx (North Carolina State University)
🗓 Jan 14 | ⏰ 12:15 PM
📍 1220 MRB III

We hope you’ll join us!

🎉 Happy New Year from #VICB!

We’re kicking off the year with new publications showcasing innovative chemical biology research from our faculty and collaborators.

🔬 Read more: medschool.vanderbilt.edu/vicb/publica...

Join us for the VICB Annual Student Research Symposium!

🗓 Sept 11, 2026 | 🕗 8AM–5PM
📍 Vanderbilt University Student Life Center

Keynote: Craig Crews, Ph.D. (Yale University)

#VICB #Vanderbilt #ChemicalBiology #DrugDiscovery #Research #Symposium

Join us for the next VICB Seminar with Mei Hong (MIT)
🧠 “Deconstructing and Reconstructing Tau by Solid-State NMR”
📅 Wed, Nov 12 | 🕛 12:15 PM | 📍 1220 MRB III

#VICB #Vanderbilt #ChemicalBiology #NMR #Neuroscience

Cracking the code: How studying single cells reveals the secrets of noncoding genes In a recent study, Vanderbilt researchers address a significant gap in our understanding of how noncoding regions of the genome regulate important biological processes, such as X-chromosome inactivati...

🧬 VICB member Dr. Gregory Scott is uncovering the secrets of noncoding genes using single-cell analysis and computational tools. His work sheds new light on how our genome really functions.

🔗 medschool.vanderbilt.edu/basic-scienc...

#Genomics #VICB #VanderbiltResearch #RNA #SingleCellBiology

11 Vanderbilt faculty members selected as 2025 Chancellor Faculty Fellows Eleven outstanding faculty members from across the university have been selected for the 2025 cohort of Chancellor Faculty Fellows. Each fellow holds the title of Chancellor Faculty Fellow and receive...

👏 Congratulations to Lars Plate, Associate Professor of Chemistry and Biological Sciences and VICB member, on being named a 2025 Chancellor Faculty Fellow! We’re excited to see his continued impact at Vanderbilt and beyond! #Vanderbilt #SOMBS #VICB news.vanderbilt.edu/2025/05/01/1...

Winning the War on Bacteria Crucial research by Neil Osheroff and his lab leads to approval of the first new class of antibacterial drugs in decades. The drug, gepotidacin, developed by GlaxoSmithKline under the brand name Bluje...

VICB’s Neil Osheroff is helping lead the fight against antibiotic resistance by targeting bacterial topoisomerases—paving the way for next-gen antibiotics. Must-read feature from @VanderbiltU:
🔗 news.vanderbilt.edu/2025/04/28/w...
#VICB #Antibiotics #DrugDiscovery

Multiomic spatial atlas shows deleted in malignant brain tumors 1 (DMBT1) glycoprotein is lost in colonic dysplasia Colorectal cancer (CRC) is responsible for over 900,000 annual deaths worldwide. Emerging evidence supports pro-carcinogenic bacteria in the colonic microbiome are at least promotional in CRC develop...

New from #VICB researchers Robert Coffey & Borden Lacy: KRAS-mutant cells can transfer Rab11a+ endosomes to neighbors, promoting transformation. A novel mechanism for intercellular oncogenic signaling.

📄 doi.org/10.1002/path...

#CancerBiology #KRAS #Pathology